Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Octopus Biosafety's share price for the quarter that ended in Dec. 2024 was €0.12. Octopus Biosafety's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 14.78 Mil. Therefore, Octopus Biosafety's market cap for the quarter that ended in Dec. 2024 was €1.77 Mil.
Octopus Biosafety's quarterly market cap
increased
from Dec. 2022 (€1.04 Mil) to Dec. 2023 (€1.48 Mil) and
increased
from Dec. 2023 (€1.48 Mil) to Dec. 2024 (€1.77 Mil).
Octopus Biosafety's annual market cap
increased
from Dec. 2022 (€1.04 Mil) to Dec. 2023 (€1.48 Mil) and
increased
from Dec. 2023 (€1.48 Mil) to Dec. 2024 (€1.77 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Octopus Biosafety's Enterprise Value for Today is €23.41 Mil.
Octopus Biosafety (STU:OCR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Octopus Biosafety Market Cap Related Terms
Octopus Biosafety Market Cap Historical Data
* Premium members only.
The historical data trend for Octopus Biosafety's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Computer Hardware subindustry, Octopus Biosafety's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Octopus Biosafety Market Cap vs Hardware Industry
For the Hardware industry and Technology sector, Octopus Biosafety's Market Cap distribution charts can be found below:
* The bar in red indicates where Octopus Biosafety's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Octopus Biosafety's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Octopus Biosafety (STU:OCR) has a Market Cap of €22.88 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Octopus Biosafety and its competitors. According to the industry distribution chart, Octopus Biosafety ranks #2072 out of 2521 companies in the Hardware industry, placing it in the top 82.2%.
Is Octopus Biosafety's Market Cap too high?
Octopus Biosafety's current Market Cap is €22.88 Mil. Based on the distribution chart, Octopus Biosafety ranks #2072 out of 2521 companies in the Hardware industry, which is in the bottom quartile relative to peers. Overall, Octopus Biosafety has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Octopus Biosafety's Market Cap compare to SNDK and DELL?
According to the Hardware industry distribution chart, Octopus Biosafety ranks #2072 out of 2521 companies for Market Cap. This places Octopus Biosafety in the lower half of its industry. The industry median Market Cap is 206.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Hardware company?
The median Market Cap among Hardware companies is 206.55, based on 2,521 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Octopus Biosafety and its competitors. For the Hardware industry, the median Market Cap is 206.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Octopus Biosafety's current Market Cap is €22.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Octopus Biosafety stock overvalued right now?
Octopus Biosafety (STU:OCR) has a current Market Cap of €22.88 Mil. The stock's GF Value™ is €0.05, compared to a current price of €0.10 — trading 100% above its estimated fair value. The current Market Cap is €22.88 Mil. Octopus Biosafety's overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Octopus Biosafety (STU:OCR), the current Market Cap is €22.88 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Octopus Biosafety (STU:OCR) Overvalued in 2026?
Based on GuruFocus' analysis, Octopus Biosafety stock appears to be overvalued.
The current stock price of €0.10 is trading 100% above its estimated GF Value™ of €0.05.
Key valuation signals for STU:OCR:
Market Cap: €22.88 Mil
GF Value™: €0.05 vs. price of €0.10 (100% above fair value)
No single metric tells the full story. See the STU:OCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Octopus Biosafety is engaged in the design, manufacture and marketing of mobile, autonomous, intelligent and modular robots for use in Agro-food sector, Healthcare sector, Defense sector, Civil Protection sector, and Surveillance and Transport sector.
11GF Score
Get the complete analysis for STU:OCR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:OCR has been successfully added to your 
